Latest Blog Posts Tagged "Research News"
December 06, 2016
Rachel Dolhun, MD, and Brian Fiske, PhD, give an overview of the promising Parkinson's research updates made in 2016.
December 02, 2016
A team from CalTech proposes a connection between gut bacteria, fatty acids, brain inflammation and Parkinson's symptoms.
December 01, 2016
Two recently published studies, one MJFF-funded, point to mutations in the GBA gene that may predispose some to cognitive problems with Parkinson's disease.
November 29, 2016
Tools developed by the winners from UC San Francisco and Weill Cornell Medicine could accelerate testing of new Parkinson's treatments by helping researchers design trials and choose study volunteers.
November 10, 2016
The trial showed the therapy is safe and tolerable and that the drug gets into the central nervous system well and reduces levels of alpha-synuclein in blood serum. Phase II expected to begin in 2017.
October 31, 2016
A new drug for levodopa-induced dyskinesia is one step closer to potentially reaching market.
October 26, 2016
An MJFF-funded study identified a new factor that may affect age of PD onset in individuals who carry a LRRK2 mutation.
October 11, 2016
In this podcast, MJFF staff scientist Marco Baptista, PhD, discusses the genetics and biology of LRRK2 and the role of the Foundation in advancing development of LRRK2 therapeutics.
October 04, 2016
Carmen Drahl wrote an article on how MJFF has supported continued work in autophagy, an area for which Japanese biologist Yoshinori Ohsumi, PhD, won a 2016 Nobel Prize.
October 03, 2016
Dale B. Schenk, PhD, a leader in the movement to treat neurodegenerative diseases with antibodies, died September 30.